Mechanisms of bone fragility in a mouse model of glucocorticoid‐treated rheumatoid arthritis: implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja… - Arthritis & …, 2012 - Wiley Online Library
Objective Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients
with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we examined the …
被引用次数：49 相关文章

Mechanisms of bone fragility in a mouse model of glucocorticoid‐treated rheumatoid arthritis: Implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja, J Inzana… - Arthritis & …, 2012 - infona.pl
Objective Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients
with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we examined the …

Mechanisms of bone fragility in a mouse model of glucocorticoid‐treated rheumatoid arthritis: Implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja… - Arthritis & …, 2012 - Wiley Online Library
Objective Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients
with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we examined the …

[引用][C] Mechanisms of Bone Fragility in a Mouse Model of Glucocorticoid-Treated Rheumatoid Arthritis: Implications for Insufficiency Fracture Risk

M TAKAHATA, JR MAHER, SC JUNEJA… - Arthritis and …, 2012 - pascal-francis.inist.fr
Mechanisms of Bone Fragility in a Mouse Model of Glucocorticoid-Treated Rheumatoid
Arthritis: Implications for Insufficiency Fracture Risk CNRS Inist Pascal-Francis CNRS …

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja… - Arthritis and …, 2012 - pubmed.ncbi.nlm.nih.gov
Objective Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients
with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we examined the …
[HTML] nih.gov

[HTML][HTML] Mechanisms of bone fragility in a glucocorticoid-treated mouse model of rheumatoid arthritis–implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja, J Inzana… - Arthritis and …, 2012 - ncbi.nlm.nih.gov
Objective Glucocorticoid (GC) therapy is associated with increased fracture risk in
rheumatoid arthritis (RA) patients. To elucidate the cause of this increased risk, we …

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

M Takahata, JR Maher, SC Juneja, J Inzana… - Arthritis and …, 2012 - europepmc.org
Objective Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients
with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we examined the …

Mechanisms of bone fragility in a mouse model of glucocorticoid‐treated rheumatoid arthritis: Implications for insufficiency fracture risk

M Takahata, JR Maher, SC Juneja, J Inzana… - Arthritis & …, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p>
Glucocorticoid (GC) therapy is associated with increased risk of fracture in patients with …
[PDF] researchgate.net

[PDF][PDF] Mechanisms of Bone Fragility in a Mouse Model of Glucocorticoid-Treated Rheumatoid Arthritis

M Takahata, JR Maher, SC Juneja… - ARTHRITIS & …, 2012 - researchgate.net
Objective. Glucocorticoid (GC) therapy is associ-ated with increased risk of fracture in
patients with rheumatoid arthritis (RA). To elucidate the cause of this increased risk, we …